If My Product Is Unlicensed, Who Do I Contact if There Is an Issue?
When it comes to medicines, understanding whether a product is licensed or unlicensed can be confusing. This is especially true in areas like medical cannabis, where patients and clinicians often navigate complex pathways to access treatment. If you have an unlicensed medicine and something goes wrong, knowing who to contact is vital. This guide explains key differences between licensed and unlicensed products, the specialist routes that exist, and the agencies and companies involved in ensuring patient safety.
Licensed vs Unlicensed Medicine Pathways
Before we talk about where to raise concerns about unlicensed products, it’s important to define these terms clearly.
Licensed medicines are products authorised by a regulatory body such as the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK. Licensing confirms that a medicine has undergone rigorous testing for safety, quality, and efficacy. Licensed products can be prescribed and supplied by dispensing pharmacies with legal safeguards in place. Unlicensed medicines, also called specials, do not hold this formal marketing authorisation. They are often used when there is no suitable licensed product available, or when a patient requires a tailored formulation. These can include named-patient specials that a doctor requests for a specific individual.
Because unlicensed medicines have not gone through the full licensing process, the responsibility for safety monitoring is different. Clinical teams, manufacturers, and regulatory agencies all play crucial roles.
Named-Patient Unlicensed Specials: What Are They?
A common route to access unlicensed medicines is the named-patient basis. A doctor writes a prescription for a special formulation tailored to a single patient. This might occur when:
No licensed medicine fits the patient’s medical needs The patient requires a unique dose form or strength A licensed product is not available in the UK at that time
These specials are made or imported by authorised manufacturers and importers who comply with UK good manufacturing practices (GMP). Records of batch and supply are maintained carefully to ensure traceability and quality control.
Who Prescribes These Unlicensed Specials?
Specialist prescribing is usually undertaken by clinicians with relevant expertise. For example, the Releaf cannabis clinic is a private UK-based prescribing clinic specialising in tailored medical cannabis treatments. Here, patients can consult qualified doctors who may prescribe unlicensed cannabis-based products legally and safely.
Similarly, medicalcannabis.co.uk provides information and facilitates access to medical cannabis under strict clinical oversight. Both clinics ensure any unlicensed products supplied come from authorised manufacturers with proper documentation.
Authorised Manufacturers and Importers: What Role Do They Play?
In the case of unlicensed medicines, authorised manufacturers produce these specials following strict standards even if they don’t hold GMP vs GACP difference a full licence. Authorised importers bring products from overseas which meet UK safety and quality requirements. They maintain detailed batch and supply records that allow them to track every unit.
If there is an issue with an unlicensed product, such as a suspected defect or adverse reaction, these manufacturers and importers are important points of contact along with the prescribing clinic and dispensing pharmacy.
If There Is an Issue, Who Should You Contact?
Problems with unlicensed medicines require clear communication channels. The key contacts include:
Your Prescribing Clinic or Specialist Doctor
As the prescriber, they must be informed promptly about any adverse events or product quality concerns. They can initiate patient safety measures and coordinate reporting. Your Dispensing Pharmacy Pharmacists handle the supply and dispensation of the product. They hold batch records and can liaise with manufacturers or importers. They also report medicines-related issues through established systems. The Manufacturer or Importer These companies have responsibility for product quality and safety. They conduct internal investigations where required and communicate findings to regulatory bodies. The Medicines and Healthcare products Regulatory Agency (MHRA) The MHRA is the regulatory authority responsible for monitoring medicines safety in the UK. Even unlicensed specials come under their oversight. You can report issues through the Yellow Card Scheme which collects information on side effects and defects to act swiftly on public health threats.
Reporting Tools and Resources
To ensure patient safety, always use authorised reporting channels. The MHRA’s Yellow Card system is national and accessible to both healthcare professionals and patients.
For clinicians and pharmacists wanting to stay informed on regulatory updates and best practices around unlicensed medicines, the Pharma Journal offers a valuable resource. Its 'Listen' audio option provides accessible briefings on topics such as batch record keeping, supply chain standards, and new guidance from the MHRA.
If your institution is interested in regular updates, registering through relevant site subscription forms—either on Pharma Journal or the MHRA’s website—can deliver tailored notifications. This ensures teams stay compliant with evolving rules on unlicensed medicine handling.
Summary Table: Who to Contact When Issues Arise With Unlicensed Products
Contact Point Role What They Do How to Reach Prescribing Clinic (e.g. Releaf cannabis clinic) Specialist doctor team Manage clinical care, report safety issues, coordinate patient follow-up By clinic appointment or contact details provided during consultation Dispensing Pharmacy Pharmacist Check batch and supply records, manage product queries, report concerns Visit in person or phone pharmacy’s contact number Authorised Manufacturer/Importer Quality and compliance teams Investigate product quality, maintain traceability, communicate with regulators Contact details on product packaging or manufacturer website MHRA UK Medicines Regulator Regulate safety, receive reports, enforce corrective measures Yellow Card Scheme, MHRA website contact forms
Key Takeaways
Unlicensed medicines, also called specials, require specialist prescribing and strict supply chain controls. Named-patient specials are supplied only for an individual after clinical evaluation. Authorised manufacturers and importers maintain batch and supply records but do not hold a full licence for these products. If you experience an issue with an unlicensed product, start by contacting your prescribing clinic and dispensing pharmacy. Report safety concerns to the MHRA via the Yellow Card Scheme to help protect all patients. Use trusted resources such as Pharma Journal and sign up for site subscription forms to stay informed.
Understanding these pathways and key contacts helps ensure safety and confidence when using unlicensed medicines. If you have questions or require further guidance, consult your healthcare team or trusted specialist providers like the Releaf cannabis clinic or medicalcannabis.co.uk for expert support.